Establishment Labs Holdings Inc Stock
Establishment Labs Holdings Inc took a tumble today and lost -€2.400 (-5.260%).
Establishment Labs Holdings Inc is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 55 € there is a positive potential of 27.31% for Establishment Labs Holdings Inc compared to the current price of 43.2 €.
So far the community has only identified positive things for Establishment Labs Holdings Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Establishment Labs Holdings Inc in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Citigroup Inc. from $49.00 to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at Mizuho from $50.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
Establishment Labs Holdings Inc. (NASDAQ: ESTA) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ESTA provided by MarketBeat
News
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today